Glioblastoma Multiforme

• CLINICAL_TRIALS research · 2017-07-11
  Clinical Trial Update: Hypofractionated Radiation Therapy for Glioblastoma [Phase 2]

  Clinical trial update on a Phase 2 hypofractionated radiation therapy study for glioblastoma. The current status is unknown.

• CLINICAL_TRIALS research · 2016-12-29
  Clinical Trial Update: Integrative Analysis of Human Glioblastoma Multiforme

  This clinical trial update indicates that the integrative analysis study of glioblastoma multiforme is currently recruiting, sponsored by Sh…

• CLINICAL_TRIALS research · 2013-12-04
  Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]

  An update on a Phase 1/Phase 2 combination chemotherapy trial for patients with recurrent glioblastoma multiforme, sponsored by Atlantic Hea…

• CLINICAL_TRIALS research · 2013-11-06
  Clinical Trial Update: Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]

  A Phase 2 clinical trial update evaluating Carmustine for progressive or recurrent glioblastoma multiforme.

• CLINICAL_TRIALS research · 2011-04-12
  Clinical Trial Update: Establishment of a Brain and Spinal Tumor Tissue Bank

  Clinical trial update describing the establishment of a brain and spinal tumor tissue bank sponsored by Taipei Medical University WanFang Ho…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2010-12-16
  Clinical Trial Update: Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme [Phase 2]

  Phase 2 clinical trial evaluating amino-acid PET-guided re-irradiation versus MRI-guided re-irradiation in patients with recurrent glioblast…

• CLINICAL_TRIALS research · 2010-10-27
  Clinical Trial Update: CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan [Phase 2]

  Phase 2 clinical trial update evaluating CT-322 with irinotecan for recurrent glioblastoma multiforme; sponsored by Adnexus (a Bristol-Myers…

• CLINICAL_TRIALS research · 2006-09-08
  Clinical Trial Update: Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) [Phase 1, Phase 2]

  A phase 1/2 safety study evaluating cetuximab with radiotherapy and temozolomide for glioblastoma multiforme; the current status is unknown.